Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract

Anticancer Research

Volumn 26, Issue 1 B, 2006, Pages 709-713

  Bar Sela, Gil ^a,b   Goldberg, Hadassah ^a   Beck, Dan ^a   Amit, Amnon ^a   Kuten, Abraham ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Iscador M ; Malignant ascites; Viscum album

Indexed keywords

ISCADOR M; VISCUM ALBUM EXTRACT;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; ADVANCED CANCER; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; PARACENTESIS; PHASE 2 CLINICAL TRIAL; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUNCTURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ASCITES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PARACENTESIS; PILOT PROJECTS; PLANT EXTRACTS; PLANT PROTEINS; PROSPECTIVE STUDIES; VISCUM ALBUM;

EID: 32144453527     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hird V, Thomas H, Stewart JS and Epenetos AA: Malignant ascites: review of the literature, and an update on monoclonal antibody-targeted therapy. Eur J Obstet Gynecol Reprod Biol 32: 37-45, 1989.
2. Gebbia N, Mannino R, Di Dino A, Maxhouni L, Bellone N, Cinque L et al: Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients. Anticancer Res 14: 739-745, 1994.
3. Mackey JR and Venner PM: Malignant ascites: demographics, therapeutic efficacy and predictors of survival. Can J Oncol 6: 474-480, 1996.
4. Grothey A, Duppe J, Hasenburg A and Voigtmann R: Use of alternative medicine in oncology patients. Dtsch Med Wochenschr 123: 923-929, 1998.
5. Hajto T, Hostanska K, Fischer J and Saller R: Immunomodulatory effects of Viscum album agglutinin-1 on natural immunity. Anticancer Drugs 8: S43-46, 1997.
6. Klopp R, Schmidt W, Niemer W, Werner M and Beuth J: Changes in immunological characteristics of white blood cells after administration of standardized mistletoe extract. In Vivo 15: 447-457, 2001.
7. Ribereau-Gayon G, Jung ML, Frantz M and Anton R: Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins. Anticancer Drugs 8: S3-8, 1997.
8. Tabiasco J, Pont F, Fournie JJ and Vercellone A: Mistletoe viscotoxins increase natural killer cell-mediated cytotoxicity. Eur J Biochem 269: 2591-2600, 2002.
9. Salzer G: Pleura carcinosis: cytomorphological findings with the mistletoe preparation Iscador and other pharmaceuticals. Oncology 43: 66-70, 1986.
10. Stumpf C and Schietzel M: Intrapleural instillation of a Viscum album [L.] extract [mistletoe] for the therapy of malignant pleural effusions: a prospective examination. Tumor Diagnostic Therapie 2: 57-61, 1994 [English translation].
11. Stumpf C and Bussing A: Stimulation of antitumour immunity by intrapleural instillation of a Viscum album L. extract. Anticancer Drugs 8: S23-26, 1997.
12. Lee CW, Bociek G and Faught W: A survey of practice in management of malignant ascites. J Pain Symptom Manage 16: 96-101, 1996.
13. Aslam N and Marino CR: Malignant ascites: new concepts in pathophysiology, diagnosis and management. Arch Intern Med 767: 2733-2737, 2001.
14. Mackey JR, Wood L, Nabholtz J, Jensen J and Venner P: A phase II trial of triamcinolone hexacetanide for symptomatic recurrent malignant ascites. J Pain Symptom Manage 19: 193-199, 2000.
15. Lissoni P, Mandala M, Curigliano G, Ferretti G, Moro C, Ardizzoia A et al: Progress report on the palliative therapy of 100 patients with neoplastic effusions by intracavitary low-dose interleukin-2. Oncol 60: 308-312, 2001.
16. Sartori S, Nielsen I, Tassinari D, Trevisani L, Abbasciano V and Malacarne P: Evaluation of a standardized protocol of intracavitary recombinant interferon alpha-2b in the palliative treatment of malignant peritoneal effusions: a prospective pilot study. Oncol 61: 192-196, 2001.
17. Nio Y, Nagami H, Tamura K, Tsubono M, Nio M, Sato M et al: Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion. Br J Cancer 80: 775-785, 1999.